Skip to main content
Yinhong Guo on Muck Rack

Yinhong Guo

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinhong

Contact Yinhong, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dabrafenib plus trametinib in an elderly patient with BRAF V600E-mutant advanced pancreatic adenocarcinoma: A case report

|
By Linger Liu, Xiaolian Zhu, Mengyao Tang, Wu Zhou, Baisong Chen, Yinhong Guo
| Frontiers
Introduction Pancreatic adenocarcinoma (PAC) represents 90% of all pancreatic cancers and is aggressive with a poor prognosis (1). It is estimated to become the second leading cause of cancer-related death in the United States by 2030, with a 5-year survival rate of about 10% (2, 3). Since the pancreas is located in the retroperitoneum, the disease often manifests insidiously with nonspecific symptoms. Most patients diagnosed at advanced stages are unable to undergo surgical resection (4).
Open in Who Shared Issue with article?
See all 1 articles